NorthStrive Biosciences Signs EL-22/EL-32 License with

NorthStrive Biosciences, a wholly owned subsidiary of PMGC Holdings Inc., has executed a definitive exclusive license agreement with Modulant Biosciences LLC for its EL-22 and EL-32 assets. The license grants Modulant an exclusive, royalty-bearing, sublicensable right to develop, manufacture, and commercialize products derived from the technologies for non-human animal health applications, including use as a feed additive.

The agreement covers issued patents, pending patent applications, and related proprietary know-how, and applies worldwide excluding the Republic of Korea. Modulant is responsible for development, manufacturing, regulatory, and commercialization activities in the animal health field, while the license expressly excludes human pharmaceutical or clinical applications.